December 30th, 2012
•A parasite-rescue and transformation assay with THP1 cells infected in vitro with Leishmania donovani has been optimized for anti-leishmanial drug screening. The assay involves differentiation of THP1 cells, infection with promastigotes, treatment with test drugs, controlled lysis of the infected macrophages, rescue of amastigotes, transformation to promastigotes and monitoring promastigote growth and proliferation with a fluorometric assay.
Tags
Vídeos Relacionados
Cutaneous Leishmaniasis in the Dorsal Skin of Hamsters: a Useful Model for the Screening of Antileishmanial Drugs
A Microscopic Phenotypic Assay for the Quantification of Intracellular Mycobacteria Adapted for High-throughput/High-content Screening
Flow Cytometric Analysis of Natural Killer Cell Lytic Activity in Human Whole Blood
System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis
Isolation of the Side Population in Myc-induced T-cell Acute Lymphoblastic Leukemia in Zebrafish
A Murine Pancreatic Islet Cell-based Screening for Diabetogenic Environmental Chemicals
Quantification of Intracellular Growth Inside Macrophages is a Fast and Reliable Method for Assessing the Virulence of Leishmania Parasites
A Suction Blister Protocol to Study Human T-cell Recall Responses In Vivo
Using Human Induced Pluripotent Stem Cell-derived Intestinal Organoids to Study and Modify Epithelial Cell Protection Against Salmonella and Other Pathogens
Rescue of Recombinant Zika Virus from a Bacterial Artificial Chromosome cDNA Clone
SOBRE A JoVE
Copyright © 2024 MyJoVE Corporation. Todos os direitos reservados